KLA CORPORATION

KLAC

CIK 0000319201 · Quarterly mode · latest period FY2026 (Q1) (ending 2026-03-31) · sourced from SEC EDGAR

At a glance · FY2026 (Q1)

Revenue
$3.42B
↑+11.5% +$352Mvs FY2025 (Q1)
Operating Income
$1.23B
↑+5.3% +$62Mvs FY2025 (Q1)
Net Income
$943M
↓-13.4% -$146Mvs FY2025 (Q1)
Gross Profit
$2.09B
↑+10.6% +$200Mvs FY2025 (Q1)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Average
47/100
  • Profitability
    46ROIC 14.2% (10% = solid, 20%+ = moat)
  • Liquidity
    100Current Ratio 2.62 (above 1.5 = solid)
  • Leverage
    37D/E 1.25 (under 0.5 = conservative)
  • Efficiency
    44Asset Turnover 0.77x (1.0+ = capital-efficient)
  • Growth
    55Revenue YoY +11.5% (10% = solid, 25%+ = elite)
  • Margin Trend
    0Insufficient data

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

DCF intrinsic value

DCF intrinsic value

two-stage Gordon model

Project KLAC's free cash flow forward, discount back at your hurdle rate, divide by diluted shares. Edit the assumptions to see how sensitive the intrinsic value is.

8%

Trailing 3-yr CAGR was 7.6%

10%

10% is a common all-equity benchmark for US large-caps

2.5%

Should be ≤ long-run GDP growth (~2.5% nominal)

5

5-year explicit projection + perpetuity terminal

Intrinsic value per share
$481.88
Total enterprise IV
$64.45B
Diluted shares
0.13B
Terminal PV
$46.72B (72% of total)
Year-5 FCF
$5.51B
YearProjected FCFDiscounted PV
+1$4.05B$3.68B
+2$4.37B$3.61B
+3$4.72B$3.55B
+4$5.10B$3.48B
+5$5.51B$3.42B
Terminal$75.24B$46.72B

DCF outputs are HIGHLY sensitive to growth + WACC assumptions. A 1pp WACC change can shift IV by 20%+. Use this as a sanity-check vs market price, not a target — and always cross-check the underlying FCF source (EDGAR cashflow statement, latest annual). Margin of safety convention: 30-50% discount to IV before buying.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
$387M
investment in PP&E
Dividends paid (TTM)
$1.01B
cash returned to holders
Stock buybacks (TTM)
$2.14B
share count reduction
Stock-based comp (TTM)
$299M
non-cash dilution

Balance sheet · 2026-03-31

latest filed snapshot
Total assets
$16.87B
everything owned
Total liabilities
$11.04B
everything owed
Stockholders' equity
$5.83B
shareholder claim
Net debt
$4.10B
LT debt minus cash

Recent performance · 68 quarters

Revenue↑+11.5% +$352M
$3.42B
Net Income↑+10.3% +$113M
$1.20B
Free Cash Flow↓-37.1% -$368M
$622M
Operating Margin↓-5.0pts
26.4%

Drill down